These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
450 related articles for article (PubMed ID: 12388624)
41. Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAIL. Johnsen JI; Pettersen I; Ponthan F; Sveinbjørnsson B; Flaegstad T; Kogner P Int J Oncol; 2004 Dec; 25(6):1849-57. PubMed ID: 15547726 [TBL] [Abstract][Full Text] [Related]
43. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance. Ng CP; Zisman A; Bonavida B Prostate; 2002 Dec; 53(4):286-99. PubMed ID: 12430140 [TBL] [Abstract][Full Text] [Related]
45. 2-methoxyestradiol up-regulates death receptor 5 and induces apoptosis through activation of the extrinsic pathway. LaVallee TM; Zhan XH; Johnson MS; Herbstritt CJ; Swartz G; Williams MS; Hembrough WA; Green SJ; Pribluda VS Cancer Res; 2003 Jan; 63(2):468-75. PubMed ID: 12543804 [TBL] [Abstract][Full Text] [Related]
46. Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcriptase promoter elicits antitumor activity without toxic effects on primary human hepatocytes. Lin T; Gu J; Zhang L; Huang X; Stephens LC; Curley SA; Fang B Cancer Res; 2002 Jul; 62(13):3620-5. PubMed ID: 12097263 [TBL] [Abstract][Full Text] [Related]
47. The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse. Canbay A; Feldstein A; Baskin-Bey E; Bronk SF; Gores GJ J Pharmacol Exp Ther; 2004 Mar; 308(3):1191-6. PubMed ID: 14617689 [TBL] [Abstract][Full Text] [Related]
48. Defining characteristics of Types I and II apoptotic cells in response to TRAIL. Ozören N; El-Deiry WS Neoplasia; 2002; 4(6):551-7. PubMed ID: 12407450 [TBL] [Abstract][Full Text] [Related]
49. Differential expression of members of the tumor necrosis factor alpha-related apoptosis-inducing ligand pathway in prostate cancer cells. Sridhar S; Ali AA; Liang Y; El Etreby MF; Lewis RW; Kumar MV Cancer Res; 2001 Oct; 61(19):7179-83. PubMed ID: 11585752 [TBL] [Abstract][Full Text] [Related]
50. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Jo M; Kim TH; Seol DW; Esplen JE; Dorko K; Billiar TR; Strom SC Nat Med; 2000 May; 6(5):564-7. PubMed ID: 10802713 [TBL] [Abstract][Full Text] [Related]
51. Involvement of TRAIL and its receptors in viral hepatitis. Mundt B; Kühnel F; Zender L; Paul Y; Tillmann H; Trautwein C; Manns MP; Kubicka S FASEB J; 2003 Jan; 17(1):94-6. PubMed ID: 12475902 [TBL] [Abstract][Full Text] [Related]
53. Prevention of bile acid-induced apoptosis by betaine in rat liver. Graf D; Kurz AK; Reinehr R; Fischer R; Kircheis G; Häussinger D Hepatology; 2002 Oct; 36(4 Pt 1):829-39. PubMed ID: 12297830 [TBL] [Abstract][Full Text] [Related]
54. Is TRAIL hepatotoxic? Gores GJ; Kaufmann SH Hepatology; 2001 Jul; 34(1):3-6. PubMed ID: 11431726 [No Abstract] [Full Text] [Related]
55. Enhanced apoptosis and tumor regression induced by a direct agonist antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 2. Motoki K; Mori E; Matsumoto A; Thomas M; Tomura T; Humphreys R; Albert V; Muto M; Yoshida H; Aoki M; Tamada T; Kuroki R; Yoshida H; Ishida I; Ware CF; Kataoka S Clin Cancer Res; 2005 Apr; 11(8):3126-35. PubMed ID: 15837769 [TBL] [Abstract][Full Text] [Related]
56. Cisplatin and a potent platinum(IV) complex-mediated enhancement of TRAIL-induced cancer cells killing is associated with modulation of upstream events in the extrinsic apoptotic pathway. Vondálová Blanárová O; Jelínková I; Szöor A; Skender B; Soucek K; Horváth V; Vaculová A; Andera L; Sova P; Szöllosi J; Hofmanová J; Vereb G; Kozubík A Carcinogenesis; 2011 Jan; 32(1):42-51. PubMed ID: 21037225 [TBL] [Abstract][Full Text] [Related]
58. TNF-related apoptosis-inducing ligand (TRAIL) induces neuronal apoptosis in HIV-encephalopathy. Miura Y; Koyanagi Y; Mizusawa H J Med Dent Sci; 2003 Mar; 50(1):17-25. PubMed ID: 12715915 [TBL] [Abstract][Full Text] [Related]
59. Blocking TRAIL-DR5 signaling with soluble DR5 reduces delayed neuronal damage after transient global cerebral ischemia. Cui M; Wang L; Liang X; Ma X; Liu Y; Yang M; Liu K; Wei X; Zhou Z; Chen YH; Sun W Neurobiol Dis; 2010 Aug; 39(2):138-47. PubMed ID: 20359534 [TBL] [Abstract][Full Text] [Related]
60. TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse. Kahraman A; Barreyro FJ; Bronk SF; Werneburg NW; Mott JL; Akazawa Y; Masuoka HC; Howe CL; Gores GJ Hepatology; 2008 Apr; 47(4):1317-30. PubMed ID: 18220275 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]